Insider Transactions in Q1 2022 at Entera Bio Ltd. (ENTX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 20
2022
|
Phillip Schwartz President of R&D |
BUY
Open market or private purchase
|
Direct |
10,000
+1.62%
|
$20,000
$2.52 P/Share
|
|
Jan 19
2022
|
Ramesh Ratan U.S.based CFO |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.44 P/Share
|
|
Jan 18
2022
|
Gerald M Lieberman Director |
BUY
Open market or private purchase
|
Indirect |
2,800
+24.14%
|
$5,600
$2.8 P/Share
|
|
Jan 18
2022
|
Spiros Jamas Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.85 P/Share
|
|
Jan 18
2022
|
Sean Ellis Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.81 P/Share
|
|
Jan 18
2022
|
Ron Mayron Director |
BUY
Open market or private purchase
|
Direct |
7,000
+50.0%
|
$14,000
$2.8 P/Share
|
|
Jan 14
2022
|
Miranda Jayne Toledano Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,800
+50.0%
|
$13,600
$2.79 P/Share
|
|
Jan 13
2022
|
Gerald M Ostrov Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.74 P/Share
|
|
Jan 13
2022
|
Yonatan Malca Director |
BUY
Open market or private purchase
|
Direct |
7,232
+50.0%
|
$14,464
$2.74 P/Share
|